$166 Million is the total value of Sio Capital Management, LLC's 31 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 150.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CBIO | Buy | CATALYST BIOSCIENCES INC | $29,670,000 | +975.4% | 1,149,989 | +468.5% | 17.83% | +1045.8% |
| SNY | New | SANOFI SAsponsored adr | $16,378,000 | – | 408,621 | +100.0% | 9.84% | – |
| KURA | Buy | KURA ONCOLOGY INC | $12,326,000 | +105.5% | 657,411 | +67.7% | 7.41% | +118.9% |
| ANTM | Buy | ANTHEM INC | $11,509,000 | +15.1% | 52,387 | +17.9% | 6.92% | +22.6% |
| BIIB | New | BIOGEN INC | $8,735,000 | – | 31,900 | +100.0% | 5.25% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $6,506,000 | +158.2% | 30,400 | +166.0% | 3.91% | +175.2% |
| LLY | Buy | ELI LILLY AND CO | $6,372,000 | +40.0% | 82,363 | +52.8% | 3.83% | +49.2% |
| MRK | New | MERCK & CO INC | $6,256,000 | – | 114,856 | +100.0% | 3.76% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $6,160,000 | +65.9% | 225,463 | +50.6% | 3.70% | +76.9% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $5,580,000 | +9.9% | 1,276,845 | +2.1% | 3.35% | +17.1% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $5,548,000 | +18.9% | 28,653 | +23.5% | 3.33% | +26.7% |
| HCA | New | HCA HEALTHCARE INC | $5,076,000 | – | 52,330 | +100.0% | 3.05% | – |
| ICLR | Buy | ICON PLC | $4,277,000 | +61.6% | 36,200 | +53.4% | 2.57% | +72.1% |
| OMI | New | OWENS & MINOR INC | $4,255,000 | – | 273,640 | +100.0% | 2.56% | – |
| CPSI | Buy | COMPUTER PROGRAMS AND SYSTEMS INC | $3,325,000 | +350.5% | 113,860 | +363.9% | 2.00% | +380.3% |
| CFMS | New | CONFORMIS INC | $3,191,000 | – | 2,200,681 | +100.0% | 1.92% | – |
| OMCL | New | OMNICELL INC | $3,048,000 | – | 70,226 | +100.0% | 1.83% | – |
| PHG | Buy | KONINKLIJKE PHILIPS NVny reg sh new | $2,940,000 | +14.7% | 76,742 | +13.1% | 1.77% | +22.2% |
| IMGN | New | IMMUNOGEN INCput | $2,891,000 | – | 274,800 | +100.0% | 1.74% | – |
| MYL | New | MYLAN NV | $2,841,000 | – | 69,000 | +100.0% | 1.71% | – |
| CELG | New | CELGENE CORP | $2,782,000 | – | 31,180 | +100.0% | 1.67% | – |
| JNJ | New | JOHNSON & JOHNSONput | $2,563,000 | – | 20,000 | +100.0% | 1.54% | – |
| MEIP | Buy | MEI PHARMA INC | $1,935,000 | +11.4% | 934,563 | +13.0% | 1.16% | +18.7% |
| HRC | New | HILL-ROM HOLDINGS INC | $1,866,000 | – | 21,449 | +100.0% | 1.12% | – |
| DERM | New | DERMIRA INC | $1,520,000 | – | 190,300 | +100.0% | 0.91% | – |
| EPZM | New | EPIZYME INC | $1,293,000 | – | 72,826 | +100.0% | 0.78% | – |
| HRTX | New | HERON THERAPEUTICS INCput | $814,000 | – | 29,500 | +100.0% | 0.49% | – |
| CRIS | New | CURIS INC | $545,000 | – | 834,551 | +100.0% | 0.33% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $474,000 | – | 193,290 | +100.0% | 0.28% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $393,000 | – | 1,076,200 | +100.0% | 0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.